MX337439B - Suspensiones novedosas de nanocristales bimetalicos basados en oro-platino, procedimientos de fabricacion electroquimica para las mismas y sus usos. - Google Patents
Suspensiones novedosas de nanocristales bimetalicos basados en oro-platino, procedimientos de fabricacion electroquimica para las mismas y sus usos.Info
- Publication number
- MX337439B MX337439B MX2013011245A MX2013011245A MX337439B MX 337439 B MX337439 B MX 337439B MX 2013011245 A MX2013011245 A MX 2013011245A MX 2013011245 A MX2013011245 A MX 2013011245A MX 337439 B MX337439 B MX 337439B
- Authority
- MX
- Mexico
- Prior art keywords
- suspensions
- metal
- bimetallic
- platinum
- gold
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
- B82B3/0009—Forming specific nanostructures
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C30/00—Alloys containing less than 50% by weight of each constituent
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C5/00—Alloys based on noble metals
- C22C5/02—Alloys based on gold
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C5/00—Alloys based on noble metals
- C22C5/04—Alloys based on a platinum group metal
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Metallurgy (AREA)
- Materials Engineering (AREA)
- Mechanical Engineering (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
- Powder Metallurgy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161469525P | 2011-03-30 | 2011-03-30 | |
| PCT/US2012/031654 WO2012135743A2 (en) | 2011-03-30 | 2012-03-30 | Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013011245A MX2013011245A (es) | 2013-10-17 |
| MX337439B true MX337439B (es) | 2016-03-03 |
Family
ID=46932416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013011245A MX337439B (es) | 2011-03-30 | 2012-03-30 | Suspensiones novedosas de nanocristales bimetalicos basados en oro-platino, procedimientos de fabricacion electroquimica para las mismas y sus usos. |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US9387225B2 (https=) |
| EP (1) | EP2691082B1 (https=) |
| JP (1) | JP6121985B2 (https=) |
| KR (2) | KR102103534B1 (https=) |
| CN (1) | CN103764123B (https=) |
| BR (1) | BR112013025112A2 (https=) |
| CA (1) | CA2829095C (https=) |
| DK (1) | DK2691082T3 (https=) |
| ES (1) | ES2564672T3 (https=) |
| IL (1) | IL228356A (https=) |
| MX (1) | MX337439B (https=) |
| PH (1) | PH12013501954A1 (https=) |
| RU (1) | RU2617055C2 (https=) |
| SG (1) | SG193439A1 (https=) |
| WO (1) | WO2012135743A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE053226T2 (hu) * | 2007-07-11 | 2021-06-28 | Clene Nanomedicine Inc | Folyamatos eljárás folyadékok kezelésére és egyes alkotórészek elõállítására |
| EP2735389A1 (de) * | 2012-11-23 | 2014-05-28 | Universität Duisburg-Essen | Verfahren zur Herstellung reiner, insbesondere kohlenstofffreier Nanopartikel |
| JP5891320B1 (ja) * | 2015-02-12 | 2016-03-22 | 秋田県 | ゼータ電位制御法を用いた処理方法 |
| CN106680450B (zh) * | 2017-03-23 | 2023-04-25 | 江西省农业科学院农业经济与信息研究所 | 水质监测装置及方法 |
| US11674234B1 (en) * | 2020-09-30 | 2023-06-13 | National Technology & Engineering Solutions Of Sandia, Llc | Electrodeposited platinum-gold alloy |
| CN112683710B (zh) * | 2020-12-02 | 2024-04-16 | 大连理工大学 | 一种氯离子侵蚀下钢筋混凝土桥板加速腐蚀的试验装置 |
| CN112935273A (zh) * | 2021-01-26 | 2021-06-11 | 哈尔滨理工大学 | 一种室温制备CuPt合金纳米颗粒的方法 |
| JP2022131579A (ja) | 2021-02-26 | 2022-09-07 | キオクシア株式会社 | 分析装置および分析方法 |
| CN113500199B (zh) * | 2021-06-10 | 2022-11-08 | 浙江大学 | 一种基于金铂双金属活性氧自生成纳米材料的制备方法及其产品和应用 |
| CN113777034B (zh) * | 2021-08-20 | 2024-04-19 | 嘉兴学院 | 金纳米双锥阵列基底及其制备方法和应用 |
| CN114470201B (zh) * | 2021-12-24 | 2024-03-19 | 上海市儿童医院 | 一种装载kcna5抗体的金铂纳米颗粒及其制备方法和应用 |
| CN120504491B (zh) * | 2025-07-21 | 2025-09-16 | 景德镇学院 | 一种稳定陶瓷釉料烧制发色的添加剂及其方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3679801A (en) * | 2000-02-08 | 2001-08-20 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| US6989157B2 (en) * | 2000-07-27 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Dry powders of metal-containing compounds |
| US7001617B2 (en) * | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
| JP2002212102A (ja) * | 2001-01-23 | 2002-07-31 | Ainobekkusu Kk | 電気化学的生理活性微粒子 |
| JP2004529929A (ja) * | 2001-04-23 | 2004-09-30 | ニュクリスト ファーマシューティカルズ コーポレーション | アポトーシスの誘導およびマトリックスメタロプロテイナーゼの阻害のための金属の使用 |
| US20080190770A1 (en) * | 2004-04-26 | 2008-08-14 | Cap Technologies, Llc | Treatment of Fluids and/or Sludge with Electro Plasma |
| JPWO2006101106A1 (ja) * | 2005-03-23 | 2008-09-04 | アプト株式会社 | 貴金属ナノコロイド溶液 |
| US20080277272A1 (en) * | 2006-01-03 | 2008-11-13 | David Kyle Pierce | Methods and Apparatuses for Making Liquids More Reactive |
| KR100857389B1 (ko) * | 2006-06-30 | 2008-09-11 | (주)아모레퍼시픽 | Ａｐ-ｇｒｒ 펩티드 또는 ａｐ-ｇｒｒ 펩티드를 포함하는펩티드사슬 및 이를 포함하는 약물전달담체 |
| TW200819540A (en) | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| HUE053226T2 (hu) | 2007-07-11 | 2021-06-28 | Clene Nanomedicine Inc | Folyamatos eljárás folyadékok kezelésére és egyes alkotórészek elõállítására |
| KR20100123674A (ko) * | 2007-09-21 | 2010-11-24 | 싸이티뮨 사이언스, 인크. | 나노치료제 콜로이드성 금속 조성물 및 방법 |
| KR101712682B1 (ko) * | 2009-01-15 | 2017-03-07 | 클레네 나노메디슨, 인크. | 액체를 처리하고 액체 내의 특정 성분(예를 들어, 나노입자)을 제조하기 위한 연속적, 반연속적 및 일괄식 방법, 장치 및 그로부터 생성된 나노입자 및 나노입자/액체 용액(들) 및 콜로이드 |
| SG10202108051XA (en) * | 2009-07-08 | 2021-09-29 | Clene Nanomedicine Inc | Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor |
| KR101090431B1 (ko) * | 2009-08-19 | 2011-12-07 | 삼성전기주식회사 | 금속 씨앗을 이용한 금속 나노입자의 제조 방법 및 금속 씨앗을 함유하는 금속 나노입자 |
-
2012
- 2012-03-12 PH PH1/2013/501954A patent/PH12013501954A1/en unknown
- 2012-03-30 US US14/008,931 patent/US9387225B2/en active Active
- 2012-03-30 RU RU2013148011A patent/RU2617055C2/ru active
- 2012-03-30 WO PCT/US2012/031654 patent/WO2012135743A2/en not_active Ceased
- 2012-03-30 SG SG2013068861A patent/SG193439A1/en unknown
- 2012-03-30 DK DK12764547.1T patent/DK2691082T3/en active
- 2012-03-30 MX MX2013011245A patent/MX337439B/es active IP Right Grant
- 2012-03-30 ES ES12764547.1T patent/ES2564672T3/es active Active
- 2012-03-30 JP JP2014502869A patent/JP6121985B2/ja active Active
- 2012-03-30 CA CA2829095A patent/CA2829095C/en active Active
- 2012-03-30 EP EP12764547.1A patent/EP2691082B1/en active Active
- 2012-03-30 KR KR1020197006058A patent/KR102103534B1/ko active Active
- 2012-03-30 BR BR112013025112-3A patent/BR112013025112A2/pt not_active Application Discontinuation
- 2012-03-30 CN CN201280016524.9A patent/CN103764123B/zh active Active
- 2012-03-30 KR KR1020137028744A patent/KR101955735B1/ko active Active
-
2013
- 2013-09-11 IL IL228356A patent/IL228356A/en active IP Right Grant
-
2016
- 2016-07-07 US US15/204,534 patent/US20160317578A1/en not_active Abandoned
-
2022
- 2022-03-30 US US17/708,253 patent/US20230172975A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ617018A (en) | 2015-10-30 |
| CN103764123A (zh) | 2014-04-30 |
| KR20140020310A (ko) | 2014-02-18 |
| EP2691082B1 (en) | 2016-01-13 |
| KR102103534B1 (ko) | 2020-04-23 |
| ES2564672T3 (es) | 2016-03-28 |
| CN103764123B (zh) | 2018-03-13 |
| RU2013148011A (ru) | 2015-05-10 |
| IL228356A (en) | 2017-04-30 |
| CA2829095A1 (en) | 2012-10-04 |
| US20140294963A1 (en) | 2014-10-02 |
| EP2691082A2 (en) | 2014-02-05 |
| JP6121985B2 (ja) | 2017-04-26 |
| US9387225B2 (en) | 2016-07-12 |
| US20160317578A1 (en) | 2016-11-03 |
| KR101955735B1 (ko) | 2019-03-07 |
| US20230172975A1 (en) | 2023-06-08 |
| CA2829095C (en) | 2019-08-27 |
| BR112013025112A2 (pt) | 2020-09-29 |
| PH12013501954A1 (en) | 2013-11-25 |
| WO2012135743A2 (en) | 2012-10-04 |
| WO2012135743A3 (en) | 2014-05-01 |
| AU2012236213A1 (en) | 2013-11-14 |
| EP2691082A4 (en) | 2015-06-24 |
| DK2691082T3 (en) | 2016-02-29 |
| RU2617055C2 (ru) | 2017-04-19 |
| AU2012236213A2 (en) | 2014-01-23 |
| SG193439A1 (en) | 2013-10-30 |
| JP2014518847A (ja) | 2014-08-07 |
| IL228356A0 (en) | 2013-12-31 |
| MX2013011245A (es) | 2013-10-17 |
| KR20190027933A (ko) | 2019-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX337439B (es) | Suspensiones novedosas de nanocristales bimetalicos basados en oro-platino, procedimientos de fabricacion electroquimica para las mismas y sus usos. | |
| PH12017501884A1 (en) | Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor | |
| MX2026002469A (es) | Nuevas moleculas de acido nucleico artificiales | |
| MX2016005668A (es) | Formas cristalinas de compuestos terapeuticos y sus usos. | |
| WO2014066850A3 (en) | Metastable silver nanoparticle composites | |
| MX391741B (es) | Composicion farmaceutica para prevenir o tratar el cancer de mama que incluye polimorfo cristalino de hexaoxido de tetraarsenico y metodo para preparar el mismo | |
| MX2019005737A (es) | Composicion farmaceutica para prevenir o tratar el cancer de cerebro que incluye polimorfocristalino de hexaoxido de tetraarsenico y metodo para preparar el mismo. | |
| EA201171279A1 (ru) | Производство инкапсулированных наночастиц с высокой объемной долей | |
| EP3466882A4 (en) | METHOD FOR PRODUCING SILICONE COMPOUND COATED OXIDE PARTICLES, SILICONE COMPOUND COATED OXIDE PARTICLES, AND SILICONE COMPOUND COATED OXID COMPOSITION THEREWITH | |
| EP4495059A3 (en) | Silicon nanoparticles for use in treating kidney diseases | |
| EP4257615A4 (en) | SELF-ASSEMBLED NANOPARTICLE CONTAINING EB VIRUS GB PROTEIN, ITS PREPARATION METHOD AND ITS USE | |
| AR103215A1 (es) | Composición farmacéutica que comprende plasminógeno y usos de este | |
| BR112017025631A2 (pt) | composições oftálmicas aquosas, método de induzir ou aumentar a formação de lágrima, método de formação de aglomerados de ciclosporina a e uso de ciclosporina a | |
| MX2016000131A (es) | Nanoparticulas polimericas de docetaxel para el tratamiento de cancer. | |
| EP3424877A4 (en) | SILVER-CONTAINING CALCIUM PHOSPHATE SINTERED BODY AND METHOD FOR THE PRODUCTION THEREOF | |
| EA201491691A1 (ru) | Агрегаты наночастиц, содержащие остеопонтин и кальций- и/или стронцийсодержащие частицы | |
| MA37676B1 (fr) | Nouveau promédicament de rebamipide, son procédé de fabrication et son utilisation | |
| AR063825A1 (es) | Metodo de tratamiento para telas y composicion para impartir hidrofobicidad diferencial | |
| MX2019014310A (es) | Agente para prevenir o tratar atrofia cerebral. | |
| Zhang et al. | Green synthesis and fabrication of an electrochemical and colorimetric sensor based on self-assembled peptide-Au nanofibril architecture | |
| EP2949454A3 (en) | Hydrogels and medical devices with pure nano-particles embedded | |
| BR112015004469A2 (pt) | sirna e seu uso em métodos e composições para o tratamento e/ou prevenção de condições oculares | |
| EP3552610A4 (en) | INORGANIC COMPOSITION WITH EXCELLENT PROPERTIES FOR THE STEP-BY-STEP RELEASE OF ZINCIONS AND PRODUCTION METHOD THEREFOR | |
| Wang et al. | A facile method to in situ formation of hydroxyapatite single crystal architecture for enhanced osteoblast adhesion | |
| EP3919585A4 (en) | QUANTUM-DOT CONTAINING NANOPARTICLES AND PROCESS FOR THE PRODUCTION THEREOF |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |